Brushing Up on APP—Mint-y Fresh Signaling Pathways Uncovered
Our understanding of amyloid precursor protein’s (APP’s) effects on the cell gained new insight this week...
6389 RESULTS
Sort By:
Our understanding of amyloid precursor protein’s (APP’s) effects on the cell gained new insight this week...
For all the scrutiny of the amyloid precursor protein (APP) as the source of pathogenic Aβ peptides, there is little understanding of the parent protein’s normal role in neurons...
The December 14 issue of Archives of Neurology features three papers and an editorial from scientists at Washington University in St Louis, Missouri...
Leptin, the satiety hormone that signals when to say when at big holiday feasts, also seems to guard against Alzheimer disease...
Partygoers familiar with conga line chaos probably know more about the formation of amyloid fibrils than they realize...
Researchers often divide their subjects by age in studies of memory, but it looks like they must also divide them by performance...
Tarenflurbil, aka flurizan, a γ-secretase modulator that showed promise in early preclinical and clinical trials, failed in Phase 3...
It appears that Dublin-based Elan's small molecule drug candidate ELND005 has run into some trouble...
It is not just material goods that are best when they come in small packages, but amyloid-β (Aβ) as well...
Swapping a single cytosine for a thymine in a gene involved in protein secretion more than doubles a person’s risk of amyotrophic lateral sclerosis (ALS)...
It may be time to add “slowing amyotrophic lateral sclerosis” to the growing list of tasks accomplished by microRNAs...
Researchers report that a mere doubling of brain LDLR levels in AD transgenic mice is enough to substantially curb deposition and hasten clearance of Aβ...
SORLA (aka SORL1) controls the trafficking and processing of the amyloid precursor protein (APP), and thus serves as a key regulator of amyloid-β...
Chicago: Axonal Transport Not So Fast in Neurodegenerative Disease Chicago: Tau and α-Synuclein Oligomers Follow Aβ Footsteps Chicago: Nicotinic AChRs: α4β2 Iffy for AD, More Promise With α7? Chicago: Move Over, Agonists; Make Way for Modulators Chicago:
Pyroglutamate Aβ has been making a return to center stage in AD research after languishing in relative obscurity for a decade following its initial discovery...